FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3660611000001107: Gliclazide 30mg modified-release tablets 56 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22290701000001110 Gliclazide 30mg modified-release tablets 56 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22290801000001118 Gliclazide 30mg modified-release tablets 56 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


17 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gliclazide 30mg modified-release tablets 56 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 56 tablet Is pack of Gliclazide 30mg m/r tablet false Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 56 tablet Has active ingredient Gliclazide false Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 56 tablet Has VMP Gliclazide 30mg modified-release tablets true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 56 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 56 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 56 tablet Has VMP Gliclazide 30mg m/r tablet false Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 56 tablet Has specific active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 56 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 56 tablet Has VMP Gliclazide 30mg modified-release tablets false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Diamicron 30mg MR tablets (Servier Laboratories Limited) 56 tablet 2 x 28 tablets Is a True Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is a True Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Accord Healthcare Ltd) 56 tablet 4 x 14 tablets Is a True Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Diamicron 30mg MR tablets (PI) (Waymade Ltd) 56 tablet Is a True Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Krka UK Ltd) 56 tablet 4 x 14 tablets Is a True Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Is a True Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (UniChem Ltd) 56 tablet Is a False Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (A A H Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is a False Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Diamicron 30mg MR tablets (Doncaster Pharmaceuticals Ltd) 56 tablet Is a True Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Sigma Pharmaceuticals Plc) 56 tablet Is a False Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Teva UK Ltd) 56 tablet 4 x 14 tablets Is a True Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) 56 tablet 4 x 14 tablets Is a True Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Edicil MR 30mg tablets (Ratiopharm UK Ltd) 56 tablet 4 x 14 tablets Is a True Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Dacadis MR 30mg tablets (Viatris UK Healthcare Ltd) 56 tablet 4 x 14 tablets Is a True Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Diamicron 30mg MR tablets (Necessity Supplies Ltd) 56 tablet Is a True Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Vitile XL 30mg tablets (Actavis UK Ltd) 56 tablet 4 x 14 tablets Is a True Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Waymade Healthcare Plc) 56 tablet Is a False Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Phoenix Healthcare Distribution Ltd) 56 tablet Is a False Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Actavis UK Ltd) 56 tablet 2 x 28 tablets Is a False Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) 56 tablet Is a True Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Vamju 30mg modified-release tablets (AMCo) 56 tablet 4 x 14 tablets Is a True Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (DE Pharmaceuticals) 56 tablet Is a False Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Is a False Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Bilxona 30mg modified-release tablets (Accord Healthcare Ltd) 56 tablet 4 x 14 tablets Is a True Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Zicron PR 30mg tablets (Bristol Laboratories Ltd) 56 tablet 4 x 14 tablets Is a True Gliclazide 30mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start